Maui Derm Caribbean 2023 Program

January 11-14, 2023 • Hilton Aruba  •  Palm Beach, Aruba

TimeTuesday, January 9, 2024Faculty
2:00 pm – 6:00 pm On-Site Registration

TimeWednesday, January 10, 2024Faculty
7:00 am – 7:50 am Breakfast, Exhibits & Registration
7:50 am – 8:00 am Welcome & Program Overview
J. Fowler, MD
8:00 am – 9:00 am Literature in Review from 2023
Drs. Ted Rosen and Jean Bolognia will discuss the best articles published in 2023 from a wide array of journals that they found noteworthy.
T. Rosen, MD
J. Bolognia, MD
9:00 am – 10:00 am New Products & New Therapies
Drs. Ted Rosen and George Martin will discuss the newest drugs and therapies and how you will be using them in 2024 and beyond.
T. Rosen, MD
G. Martin, MD
10:00 am -10:45 amBreak + Exhibits
10:45 am – 11:45 amUpdate Cutaneous Oncology 2024: Part 1
Drs. Rosen, Schmults and Martin will cover their approach from AKs to advanced BCC and SCC.
G. Martin, MD
T. Rosen, MD
C. Schmults, MD
11:45 am – 12:15 pmUpdate in Cutaneous Oncology 2024: Part 2 (Non-CME Event)
Drs. Rosen, Schmults and Martin will cover their approach from AKs to advanced BCC and SCC.
G. Martin, MD
T. Rosen, MD
C. Schmults, MD
INDUSTRY HOSTED EVENT
12:15 pm – 12:45 pm
Product Theater Luncheon hosted by Incyte (Non-CME)
A Targeted Approach to the Treatment of Nonsegmental Vitiligo
Speaker: Dr. Peter Lio
12:45 pm – 1:15 pmUrticaria Update 2024: From Acute To Chronic Idiopathic Urticaria (Non-CME)
The clinical approach to diagnosing and treating a wide range of urticarias from physical urticarias to chronic idiopathic urticaria will be discussed.
Faculty:
J. Hawkes, MD
1:15 pm – 3:00 pmChallenging Cases in Dermatology
Our faculty members have been asked to bring their most challenging cases in which the diagnosis was uncertain and the path to a diagnosis included “super sleuthing”.
Moderator:
J. Fowler, MD
J. Bolognia, MD
C. Ellis, MD
B. Lushniak, MD
J. Harper, MD
H. Baldwin, MD
3:00 pmSessions Adjourn
INDUSTRY HOSTED EVENT
3:30 pm – 4:00 pm
Product Theater hosted by Dermavant (Non-CME)
VTAMA® (tapinarof) cream, 1%:​ Phase 4 Open-Label Trial for the Treatment of Intertriginous Plaque Psoriasis  ​
Speaker: Dr. Ben Lockshin
6:00 pm – 9:00 pmWelcome Dinner
Take off your shoes and join us for a memorable evening on the beach just steps away from the ocean. We have planned for a sunset and evening filled with fabulous food and engaging conversation with colleagues. Definitely “an evening to remember”.

TimeThursday, January 11, 2024Faculty
INDUSTRY HOSTED EVENT
7:00 am – 7:30 am
Product Theater Breakfast hosted by Lilly (Non-CME)
STEP INTO POSSIBILITY: EXPLORE OLUMIANT 2-YEAR DATA
Speaker: Chesahna Kindred, MD, MBA, FAAD
7:00 am – 7:55 am Breakfast & Exhibits
7:55 am – 8:00 am Morning Announcements
J. Fowler, MD
8:00 am – 9:00 am Pediatric Dermatology Update 2024
Two of the foremost pediatric dermatologists will bring the latest in diagnostic and therapeutic approaches to a wide range of diagnostic and therapeutic scenarios involving neonates and children.
A. Yan, MD
A. Hebert, MD
9:00 am – 10:00 am Infectious Disease Update 2024
The ever-changing world of infectious diseases presenting in adults and children will be discussed by our two expert faculty.
T. Rosen, MD
A. Yan, MD
10:00 am -10:45 amBreak + Exhibits
10:45 am – 11:45 amPsoriasis Update 2024: Part 1
Our multidisciplinary panel includes world-class dermatologists and a rheumatologist who will discuss their approach to psoriasis and psoriatic arthritis presenting in a wide range of clinical scenarios.
Moderator:
G. Martin, MD

Faculty:
A. Hebert, MD
A. Kavanaugh, MD
J. Cather, MD
J. Hawkes, MD
11:45 am – 12:15 pmPsoriasis Update 2024: Part 2 (Non-CME)
Our multidisciplinary panel includes world-class dermatologists and a rheumatologist who will discuss their approach to psoriasis and psoriatic arthritis presenting in a wide range of clinical scenarios.
Moderator:
G. Martin, MD

Faculty:
A. Hebert, MD
A. Kavanaugh, MD
J. Cather, MD
J. Hawkes, MD
INDUSTRY HOSTED EVENT
12:15 pm – 12:45 pm
Product Theater Luncheon hosted by Janssen (Non-CME)
VISIBLE results across all skin tones with TREMFYA®: A first-of-its-kind study in plaque psoriasis (PsO)
Speaker: Dr. Tiffany Clay-Ramsey
12:45 pm – 1:30 pmWounds and Wound Healing (Non-CME)
Dr. Robert Kirsner, a world authority on wound healing, will discuss the latest in managing a wide variety of wounds.
R. Kirsner, MD, PhD
1:30 pm – 2:00 pmDisorders of Pigmentation
Dr. Andrew Alexis will discuss his approach to diagnosing and treating disorders of pigmentation ranging from melasma to vitiligo.
A. Alexis, MD
2:00 pm – 3:00 pmChallenging Cases in Pediatric Dermatology
General dermatologists never seem to get comfortable with those “one off” diagnostic or therapeutic challenges that present in newborns and children. In this session our two brilliant pediatric dermatologists will discuss their “seasoned approach” to diagnostic and therapeutic conundrums presenting in newborns and children.
A. Yan, MD
A. Hebert, MD
3:00 pmSessions Adjourn
INDUSTRY HOSTED EVENT
4:00 pm – 4:30 pm
Product Theater hosted by UCB Inc.
BIMZELX® has Arrived
Dr. Jeffrey LaDuca

TimeFriday, January 12, 2024Faculty
INDUSTRY HOSTED EVENT
7:00 am – 7:30 am
Product Theater Breakfast hosted by Novartis (Non-CME)
The Latest Approved Indication for COSENTYX® (secukinumab)
Speaker: Ryan Sullivan, MD
7:00 am – 7:55 am Breakfast & Exhibits
7:55 am – 8:00 am Morning Announcements
J. Fowler, MD
8:00 am – 8:50 am Connective Tissue Disorders Update 2024
Dr. Werth, one of the leading experts in the area of connective tissue disorders will present the latest in therapies that are evolving for these disorders which include lupus, dermatomyositis and scleroderma.
V. Werth, MD
8:50 am – 10:00 am Hair Update 2024
As the song goes: “nobody does it better”, Dr. Jerry Shapiro continues to deliver the most comprehensive and cutting edge talk on non-scarring and scarring alopecias.
J. Shapiro, MD
10:00 am -10:45 amBreak + Exhibits
10:45 am – 11:45 amAtopic Dermatitis and Itch Update 2024: Part 1
The therapeutic options for atopic dermatitis and pruritus represent are a rapidly changing landscape. New biologics, new applications for existing biologics, oral systemics including JAK inhibitors and new and novel “non-steroidal” topicals have created a medicine cabinet full of choices. Our expert faculty will discuss the “how, when, where and why” to use these therapeutic options. Dr. Fowler will discuss the role of patch testing and allergy testing in AD patients.
Moderator:
G. Martin, MD

Faculty:
A. Yan, MD
P. Lio, MD
G. Yosipovitch, MD, PhD
J. Fowler, MD
11:45 am – 12:15 pmAtopic Dermatitis and Itch Update 2024: Part 2 (Non-CME)
The therapeutic options for atopic dermatitis and pruritus represent are a rapidly changing landscape. New biologics, new applications for existing biologics, oral systemics including JAK inhibitors and new and novel “non-steroidal” topicals have created a medicine cabinet full of choices. Our expert faculty will discuss the “how, when, where and why” to use these therapeutic options. Dr. Fowler will discuss the role of patch testing and allergy testing in AD patients.
Moderator:
J. Fowler, MD

Faculty:
A. Yan, MD
P. Lio, MD
G. Yosipovitch, MD, PhD
J. Fowler, MD
INDUSTRY HOSTED EVENT
12:15 pm – 12:45 pm
Product Theater Luncheon hosted by AbbVie (Non-CME)
Experiencing Real Relief
Speaker: Dr. Jennifer Cather
12:45 pm – 1:15 pmAcne and Rosacea Update 2024: Part 1 (Non-CME)
Drs. Hilary Baldwin and Julie Harper (aka “The Dynamic Duo of Acne and Rosacea”) will discuss the latest in their approach to treating acne and rosacea during Part 1 and 2 of their “Acne and Rosacea Update 2024”.
H. Baldwin, MD
J. Harper, MD
1:15 pm – 1:45 pmAcne and Rosacea Update 2024: Part 2
H. Baldwin, MD
J. Harper, MD
1:45 pm – 3:15 pmService Excellence
Service Excellence (another term for Customer Service) is a very hot topic in practices, especially dermatology and aesthetics practices, because high patient satisfaction is key to success. Dr. Ellis will engage you and help you to take your “practice culture” to a whole new level.
C. Ellis, MD
3:15 pmSessions Adjourn
INDUSTRY HOSTED EVENT
3:45 pm – 4:15 pm
Product Theater Reception hosted by Pfizer (Non-CME)
Discover an Oral Treatment for Severe Alopecia Areata Description: Discover an oral treatment for severe alopecia areata. Pfizer Inc., invites you to an engaging, non-CME, educational program that will cover the efficacy and safety of an FDA-approved treatment option.
Speaker: Dr. Jerry Shapiro

TimeSaturday, January 13, 2024Faculty
INDUSTRY HOSTED EVENT
7:00 am – 7:30 am
Product Theater Breakfast hosted by Sanofi and Regeneron Pharmaceuticals, Inc.  (Non-CME)
A Treatment Option for Patients With Uncontrolled Moderate-to-Severe Atopic Dermatitis   Description: Learn more about a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.
Speaker: G. Scott Drew, DO, FAOCD
7:00 am – 7:55 am Breakfast & Exhibits
7:55 am – 8:00 am Morning Announcements
J. Fowler, MD
8:00 am – 8:45 am Blistering Diseases Update 2024
Dr. Werth will discuss her approach to diagnosing and treating immunobullous diseases. She will discuss the role of existing therapies including oral systemics, topicals and monoclonal antibodies in the treatment of immunobullous diseases as well as the new therapies coming our way in 2024.
V. Werth, MD
8:45 am – 10:15 am Pigmented Lesion Clinic
Take three world experts in the diagnosis and management of pigmented lesions: a pediatric dermatologist, a dermatologist and an oncologist, all from MGH, and have them discuss their approach to a wide array of clinical scenarios involving the spectrum of pigmented lesions from congenital nevi to metastatic melanoma. You will not want to miss this session.
H. Tsao, MD, PhD
E. Hawryluk, MD, PhD
K. Flaherty, MD
10:15 am -10:45 amBreak + Exhibits
10:45 am – 11:15 amContact Dermatitis Update 2024
Dr. Joe Fowler will present practical approaches and tips to diagnosing the everyday to the unusual contact dermatitis dilemmas we face.
J. Fowler, MD
11:15 am – 11:45 amBoris on Dermatology (Non-CME)
When a retired US Surgeon General talks, people listen. Dr. Lushniak will share his experience in global dermatology.
B. Lushniak, MD
INDUSTRY HOSTED EVENT
11:45 am – 12:15 pm
Product Theater Luncheon hosted by Regeneron (Non-CME)
Co-Managing Patients with Advanced Basal Cell Carcinoma (aBCC) and Advanced Cutaneous Squamous Cell Carcinoma (aCSCC) in the Immunotherapy Era
Speaker: Andrew Weinstein, MD, FAAD
12:15 pm – 12:45 pmPractice Pearls (Non-CME)
Take more than sand in your shoes home with you when you leave Aruba. Our faculty’s “pearls” will change the way you practice starting the Monday morning that you are back in the clinic.
Moderator:
J. Fowler, MD

Faculty:
H. Tsao, MD, PhD
C. Ellis, MD
12:45 pm – 1:00 pmMeeting Wrap Up
What do you want to hear in 2025 at Maui Derm Caribbean in St. Thomas?
J. Fowler, MD